BSE filing, NSE: IVALUE. Summary written from the filing by ALFA Finder's alert engine.
Ivalue Infosolutions Ltd: key numbers
- Share price
- ₹214.18
- Market cap
- ₹1,173 Cr
- Revenue (annual)
- ₹1,056 Cr
- Net profit (annual)
- ₹98.23 Cr
- P/E (TTM)
- 11.3×Sector 22.9×
- Promoter holding
- 32.09%-0.01% QoQ
- FII holding
- 2.86%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ivalue Infosolutions Ltd
All →Ivalue Infosolutions Other Announcement
iValue Infosolutions Limited submitted the Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.
Ivalue Infosolutions Promoter Buying
Promoter Krishna Raj Sharma voluntarily acquired 35,661 equity shares of iValue Infosolutions Limited via open market purchase during the second quarter of 2026.
Ivalue Infosolutions Credit Rating
ICRA upgraded iValue Infosolutions Limited's long-term rating to [ICRA]A+ (Stable) and short-term rating to [ICRA]A1+. The upgrade reflects scaled operations and a healthy financial risk profile.
- Value
- ₹118.0 Cr
Ivalue Infosolutions Annual General Meeting
iValue Infosolutions Limited held its 18th Annual General Meeting on August 19, 2026, via video conferencing to transact business as per the meeting notice.
Ivalue Infosolutions Management Change
Ivalue Infosolutions Limited announced the resignation of CEO Shrikant Manohar Shitole and the re-appointment of S G S K & Company as internal auditor.
Ivalue Infosolutions Results Update
iValue Infosolutions Limited reported Q1FY27 gross sales of ₹641.2 crore and a net profit of ₹15.7 crore, reflecting steady operational performance and year-on-year growth.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date